As the COVID-19 crisis places extraordinary pressure on the supply chain for various essential goods, federal and state authorities have turned their focus to suspected instances of price gouging, particularly for medical and healthcare goods experiencing extraordinary demand. This memorandum provides an overview of those efforts thus far.